HL

Cue Health IncNASDAQ HLTH Stock Report

Last reporting period 31 Dec, 2023

Updated 13 Sep, 2024

Last price

Market cap $B

0.007

Micro

Exchange

XNAS - Nasdaq

HLTH Stock Analysis

HL

Uncovered

Cue Health Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-46/100

Low score

Market cap $B

0.007

Dividend yield

Shares outstanding

150.41 B

Cue Health, Inc. is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. The company is headquartered in San Diego, California. The company went IPO on 2021-09-24. The firm is engaged in providing individuals with a connected diagnostic platform that bridges the physical and virtual care continuum. Its platform, Cue Integrated Care Platform, which consists of hardware and software components: the Cue Health Monitoring System, which is made up of a portable, durable and reusable reader, or Cue Reader, a single-use test cartridge, or Cue Cartridge, and a sample collection wand, or Cue Wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its app and Cue Enterprise Dashboard, and its Cue Ecosystem Integrations and apps, which allow for integrations with third party applications and sensors. Its products include Cue Reader, COVID-19 Test, COVID-19-Cue Care, UTI Test Strips and UTI- Cue Care. The company offers solutions for home/personal, business, healthcare, retail pharmacies, sports and entertainment, and education sectors.

View Section: Eyestock Rating